Atomoxetine is manufactured, marketed, and sold in the United States as the hydrochloride salt (atomoxetine HCl) under the brand name Strattera by Eli Lilly and Company, the original patent -filing company and current U.S. patent owner. Atomoxetine works in the brain to increase attention and decrease restlessness in people who are hyperactive, have problems with concentration, or are easily distracted. This medicine may be used as part of a treatment program that includes social, educational, and psychologic treatment. Strattera is approved for the treatment of attention- deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults.older, teens, and adults. Strattera is a selective norepinephrine reuptake inhibitor medicine. It is used for the treatment of attention deficit and hyperactivity disorder (ADHD). Strattera may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD. Strattera is a treatment for attention deficit hyperactivity disorder (ADHD) to help improve attention and reduce hyperactivity and impulsiveness. Strattera works by increasing levels of norepinephrine, a chemical messenger in the brain that is involved in hyperactivity and impulse control. Easy-to-read patient tips for Strattera covering how it works, benefits, risks, and best practices. Learn about atomoxetine (Strattera) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. Strattera is used to treat ADHD in adults and some children. Find out its recommended dosages, how to take it, and more. Strattera (atomoxetine) is a non-stimulant ADHD medication. Learn side effects, uses, dosages, and warnings. Overview: Atomoxetine is used to help with attention deficit and hyperactivity disorder (ADHD) by improving focus and reducing impulsivity and hyperactivity. It works by increasing a natural.